{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T05:32:51Z","timestamp":1738474371435,"version":"3.35.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Bladder Dysfunct Rep"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s11884-008-0021-8","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T07:04:56Z","timestamp":1224054296000},"page":"133-139","source":"Crossref","is-referenced-by-count":1,"title":["Intravesical strategies to manage the neurogenic bladder"],"prefix":"10.1007","volume":"3","author":[{"given":"Paulo","family":"Dinis","sequence":"first","affiliation":[]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,10,16]]},"reference":[{"key":"21_CR1","first-page":"198","volume":"8","author":"V.W. Nitti","year":"2006","unstructured":"Nitti VW: Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art. Rev Urol 2006, 8:198\u2013208.","journal-title":"Rev Urol"},{"key":"21_CR2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","volume":"312","author":"M. Dong","year":"2006","unstructured":"Dong M, Yeh F, Tepp WH, et al.: SV2 is the protein receptor for botulinum neurotoxin A. Science 2006, 312:592\u2013596.","journal-title":"Science"},{"key":"21_CR3","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","volume":"96","author":"A. Paiva de","year":"1999","unstructured":"de Paiva A, Meunier FA, Molg\u00f3 J, et al.: Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 1999, 96:3200\u20133205.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"21_CR4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","volume":"342","author":"B. Schurch","year":"2000","unstructured":"Schurch B, Schmid DM, St\u00f6hrer M: Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 2000, 342:665.","journal-title":"N Engl J Med"},{"key":"21_CR5","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","volume":"46","author":"A. Haferkamp","year":"2004","unstructured":"Haferkamp A, Schurch B, Reitz A, et al.: Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Eur Urol 2004, 46:784\u2013791.","journal-title":"Eur Urol"},{"key":"21_CR6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1464-410X.2007.07137.x","volume":"100","author":"H. Schulte-Baukloh","year":"2007","unstructured":"Schulte-Baukloh H, Zurawski TH, Knispel HH, et al.: Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment. BJU Int 2007, 100:1075\u20131080.","journal-title":"BJU Int"},{"key":"21_CR7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","volume":"26","author":"K.R. Aoki","year":"2005","unstructured":"Aoki KR: Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 2005, 26:785\u2013793.","journal-title":"Neurotoxicology"},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0006-2952(00)00260-4","volume":"59","author":"J. Purkiss","year":"2000","unstructured":"Purkiss J, Welch M, Doward S, Foster K: Capsaicinstimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. Biochem Pharmacol 2000, 59:1403\u20131406.","journal-title":"Biochem Pharmacol"},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1242\/jcs.012211","volume":"120","author":"J. Meng","year":"2007","unstructured":"Meng J, Wang J, Lawrence G, Dolly JO: Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. Cell Sci 2007, 120:2864\u20132874.","journal-title":"Cell Sci"},{"key":"21_CR10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-410X.2007.07312.x","volume":"101","author":"A. Lucioni","year":"2008","unstructured":"Lucioni A, Bales GT, Lotan TL, et al.: Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int 2008, 101:366\u2013370.","journal-title":"BJU Int"},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)00322-8","volume":"175","author":"D.E. Rapp","year":"2006","unstructured":"Rapp DE, Turk KW, Bales GT, Cook SP: Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder. Urology 2006, 175:1138\u20131142.","journal-title":"Urology"},{"key":"21_CR12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","volume":"45","author":"M. Khera","year":"2004","unstructured":"Khera M, Somogyi GT, Kiss S, et al.: Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 2004, 45:987\u2013993.","journal-title":"Neurochem Int"},{"key":"21_CR13","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuint.2007.11.006","volume":"52","author":"C.P. Smith","year":"2008","unstructured":"Smith CP, Gangitano DA, Munoz A, et al.: Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury. Neurochem Int 2008, 52:1068\u20131075.","journal-title":"Neurochem Int"},{"key":"21_CR14","doi-asserted-by":"crossref","first-page":"25665","DOI":"10.1074\/jbc.M311515200","volume":"279","author":"C. Morenilla-Palao","year":"2004","unstructured":"Morenilla-Palao C, Planells-Cases R, Garc\u00eda-Sanz N, Ferrer-Montiel A: Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J Biol Chem 2004, 279:25665\u201325672.","journal-title":"J Biol Chem"},{"key":"21_CR15","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0022-5347(06)00258-8","volume":"175","author":"A. Giannantoni","year":"2006","unstructured":"Giannantoni A, Di Stasi SM, Nardicchi V, et al.: Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol 2006, 175:2341\u20132344.","journal-title":"J Urol"},{"issue":"3Suppl1","key":"21_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.urology.2003.11.001","volume":"63","author":"F. Cruz","year":"2004","unstructured":"Cruz F: Mechanisms involved in new therapies for overactive bladder. Urology 2004, 63(3 Suppl 1):65\u201373.","journal-title":"Urology"},{"key":"21_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","volume":"64","author":"T. Odergen","year":"1998","unstructured":"Odergen T, Hjaltason H, Kaakkola S, et al.: A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 1998, 64:6\u201312.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"21_CR18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A. Reitz","year":"2004","unstructured":"Reitz A, St\u00f6hrer M, Kramer G, et al.: European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004, 45:510\u2013515.","journal-title":"Eur Urol"},{"key":"21_CR19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B. Schurch","year":"2005","unstructured":"Schurch B, de S\u00e8ze M, Denys P, et al.: Botulinux toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. Urology 2005, 174:196\u2013200.","journal-title":"Urology"},{"key":"21_CR20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","volume":"53","author":"G. Karsenty","year":"2008","unstructured":"Karsenty G, Denys P, Amarenco G, et al.: Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. Eur Urol 2008, 53:275\u2013287.","journal-title":"Eur Urol"},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","volume":"53","author":"G. Popolo Del","year":"2008","unstructured":"Del Popolo G, Filocamo MT, Li Marzi V, et al.: Neurogenic detrusor overactivity treated with English botulinum toxin a: 8-year experience of one single centre. Eur Urol 2008, 53:1013\u20131020.","journal-title":"Eur Urol"},{"key":"21_CR22","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.eururo.2007.08.052","volume":"52","author":"A. Reitz","year":"2007","unstructured":"Reitz A, Denys P, Fermanian C, et al.: Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Eur Urol 2007, 52:1729\u20131735.","journal-title":"Eur Urol"},{"key":"21_CR23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.2007.06977.x","volume":"100","author":"M. Akbar","year":"2007","unstructured":"Akbar M, Abel R, Seyler TM, et al.: Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int 2007, 100:639\u2013645.","journal-title":"BJU Int"},{"key":"21_CR24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","volume":"49","author":"V. Kalsi","year":"2006","unstructured":"Kalsi V, Apostolidis A, Popat R, et al.: Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Eur Urol 2006, 49:528\u2013535.","journal-title":"Eur Urol"},{"key":"21_CR25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2007.04.026","volume":"52","author":"B. Schurch","year":"2007","unstructured":"Schurch B, Denys P, Kozma CM, et al.: Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence Eur Urol 2007, 52:850\u2013858.","journal-title":"Eur Urol"},{"key":"21_CR26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/00365590601068835","volume":"41","author":"I. Ehren","year":"2007","unstructured":"Ehren I, Volz D, Farrelly E, et al.: Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study. Scand J Urol Nephrol 2007, 41:335\u2013340.","journal-title":"Scand J Urol Nephrol"},{"key":"21_CR27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21209","volume":"62","author":"V. Kalsi","year":"2007","unstructured":"Kalsi V, Gonzales G, Popat R, et al.: Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann Neurol 2007, 62:452\u2013457.","journal-title":"Ann Neurol"},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2007.08.039","volume":"53","author":"X. Gam\u00e9","year":"2008","unstructured":"Gam\u00e9 X, Castel-Lacanal E, Bentaleb Y, et al.: Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol 2008, 53:613\u2013618.","journal-title":"Eur Urol"},{"key":"21_CR29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1569-9056(08)60563-1","volume":"7","author":"A. Giannantoni","year":"2008","unstructured":"Giannantoni A, Serva MR, Proietti S, et al.: Six-year follow-up of intradetrusorial injections of botulinum toxin type A in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur Urol 2008, 7:569.","journal-title":"Eur Urol"},{"key":"21_CR30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2005.11.006","volume":"49","author":"V. Kalsi","year":"2006","unstructured":"Kalsi V, Popat RB, Apostolidis A, et al.: Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre. Eur Urol 2006, 49:519\u2013527.","journal-title":"Eur Urol"},{"key":"21_CR31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.eursup.2008.01.019","volume":"7","author":"S. Boy","year":"2008","unstructured":"Boy S, Seif C, Braun P, et al.: Retrospective analysis of treatment outcomes and medical care of patients with neurogenic detrusor overactivity (NDO) receiving Botox therapy. Eur Urol 2008, 7:566.","journal-title":"Eur Urol"},{"key":"21_CR32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2006.10.047","volume":"177","author":"G. Karsenty","year":"2007","unstructured":"Karsenty G, Elzayat E, Delapparent T, et al.: Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux. J Urol 2007, 177:1011\u20131014.","journal-title":"J Urol"},{"key":"21_CR33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/nau.20515","volume":"27","author":"F. Mascarenhas","year":"2008","unstructured":"Mascarenhas F, Cocuzza M, Gomes CM, Le\u00e3o N: Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients. Neurourol Urodyn 2008, 27:311\u2013314.","journal-title":"Neurourol Urodyn"},{"key":"21_CR34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1569-9056(08)60567-9","volume":"7","author":"M. Citeri","year":"2008","unstructured":"Citeri M, Spinelli M, Zanollo L, et al.: Botulinum toxin into the trigone in neurogenic overactive bladder nonresponder to detrusor injection. Eur Urol 2008, 7:571.","journal-title":"Eur Urol"},{"key":"21_CR35","first-page":"570","volume":"7","author":"C.H. Lang","year":"2008","unstructured":"Lang CH, Eichel R, Alloussi SH, et al.: Botulinum toxin A (Dysport), a safe modern treatment regime in the therapy of drug refractory detrusor overactivity, 5 years of clinical experience Eur Urol 2008, 7:570.","journal-title":"Eur Urol"},{"key":"21_CR36","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","volume":"50","author":"E. Comp\u00e9rat","year":"2006","unstructured":"Comp\u00e9rat E, Reitz A, Delcourt A, et al.: Histologic features in the urinary bladder wall affected from neurogenic overactivity\u2014a comparison of inflammation, oedema, and fibrosis with and without injection of botulinum toxin type A. Eur Urol 2006, 50:1058\u20131064.","journal-title":"Eur Urol"},{"key":"21_CR37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-4295(01)01641-7","volume":"59","author":"H. Schulte-Baukloh","year":"2002","unstructured":"Schulte-Baukloh H, Michael T, Schobert J, et al.: Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 2002, 59:325\u2013328.","journal-title":"Urology"},{"key":"21_CR38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/nau.10005","volume":"21","author":"J. Corcos","year":"2002","unstructured":"Corcos J, Al-Taweel W, Pippi Salle J, et al.: The treatment of detrusor hyperreflexia using botulinum A toxin in myelomeningocele patients unresponsive to anticholinergic. Neurourol Urodyn 2002, 21:332\u2013333.","journal-title":"Neurourol Urodyn"},{"issue":"3Pt1","key":"21_CR39","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-5347(05)00400-3","volume":"175","author":"W. Altaweel","year":"2006","unstructured":"Altaweel W, Jednack R, Bilodeau C, Corcos J: Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele. J Urol 2006, 175(3 Pt 1):1102\u20131105.","journal-title":"J Urol"},{"key":"21_CR40","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","volume":"389","author":"M.J. Caterina","year":"1997","unstructured":"Caterina MJ, Schumacher MA, Tominaga M, et al.: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816\u2013824.","journal-title":"Nature"},{"key":"21_CR41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3959(00)00353-5","volume":"88","author":"P. Hayes","year":"2000","unstructured":"Hayes P, Meadows J, Gunthorpe MJ, et al.: Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain 2000, 88:205\u2013215.","journal-title":"Pain"},{"key":"21_CR42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0031-6997(24)01403-0","volume":"51","author":"A. Szallasi","year":"1999","unstructured":"Szallasi A, Blumberg PM: Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999, 51:159\u2013211.","journal-title":"Pharmacol Rev"},{"issue":"Suppl","key":"21_CR43","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/0165-1838(90)90105-R","volume":"30","author":"W.C. Groat de","year":"1990","unstructured":"de Groat WC, Kawatani M, Hisamitsu T, et al.: Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 1990, 30(Suppl):S71\u2013S77.","journal-title":"J Auton Nerv Syst"},{"key":"21_CR44","first-page":"507","volume-title":"Textbook of the Neurogenic Bladder","author":"C. Silva","year":"2004","unstructured":"Silva C, Cruz F: Intravesical pharmacological therapy. In Textbook of the Neurogenic Bladder, edn 1. Edited by Corcos J, Schick E. London: Martin Dunitz; 2004:507\u2013517.","edition":"edn 1"},{"key":"21_CR45","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/(SICI)1520-6777(1998)17:5<513::AID-NAU7>3.0.CO;2-G","volume":"17","author":"M. S\u00e9ze de","year":"1998","unstructured":"de S\u00e9ze M, Wiart L, Joseph PA, et al.: Capsaicin and neurogenic detrusor hyperreflexia. A double blind placebo controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 1998, 17:513\u2013523.","journal-title":"Neurourol Urodyn"},{"key":"21_CR46","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0140-6736(92)91186-C","volume":"339","author":"C.J. Fowler","year":"1992","unstructured":"Fowler CJ, Jewkes D, McDonald WI, et al.: Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 1992, 339:1239.","journal-title":"Lancet"},{"key":"21_CR47","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/nau.20296","volume":"25","author":"M. S\u00e8ze de","year":"2006","unstructured":"de S\u00e8ze M, Gallien P, Denys P, et al.: Intravesical glucidic capsaicin versus glucidic solvent in neurogenic detrusor overactivity: a double blind controlled randomized study. Neurourol Urodyn 2006, 25:752\u2013757.","journal-title":"Neurourol Urodyn"},{"key":"21_CR48","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(05)63330-2","volume":"350","author":"F. Cruz","year":"1997","unstructured":"Cruz F, Guimar\u00e3es M, Silva C, Reis M: Suppression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet 1997, 350:640\u2013641.","journal-title":"Lancet"},{"key":"21_CR49","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0022-5347(01)68164-3","volume":"158","author":"M. Lazzeri","year":"1997","unstructured":"Lazzeri M, Beneforti P, Turini D: Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor. J Urol 1997, 158:2093\u20132096.","journal-title":"J Urol"},{"key":"21_CR50","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1159\/000020322","volume":"38","author":"C. Silva","year":"2000","unstructured":"Silva C, Rio ME, Cruz F: Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. Eur Urol 2000, 38:444\u2013452.","journal-title":"Eur Urol"},{"key":"21_CR51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/003655998750015287","volume":"32","author":"M. Lazzeri","year":"1998","unstructured":"Lazzeri M, Spinelli M, Beneforti P, et al.: Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases. Scand J Urol Nephrol 1998, 32:331\u2013334.","journal-title":"Scand J Urol Nephrol"},{"key":"21_CR52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2005.04.012","volume":"48","author":"C. Silva","year":"2005","unstructured":"Silva C, Silva J, Ribeiro MJ, et al.: Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial. Eur Urol 2005, 48:650\u2013655.","journal-title":"Eur Urol"},{"key":"21_CR53","first-page":"41","volume":"21","author":"M. S\u00e8ze de","year":"2002","unstructured":"de S\u00e8ze M, Wiart L, de S\u00e8ze M, et al.: Efficacy and tolerance of intravesical instillation of capsaicin and resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients. A double-blind controlled study: preliminary results [abstract]. Neurourol Urodyn 2002, 21:41\u201342.","journal-title":"Neurourol Urodyn"},{"key":"21_CR54","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0022-5347(05)65183-X","volume":"167","author":"A. Giannantoni","year":"2002","unstructured":"Giannantoni A, Di Stasi SM, Stephen RL, et al.: Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol 2002, 167:1710\u20131714.","journal-title":"J Urol"},{"key":"21_CR55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000019531","volume":"33","author":"P. Dasgupta","year":"1998","unstructured":"Dasgupta P, Chandiramani V, Parkinson MC, et al.: Treating the human bladder with capsaicin: is it safe? Eur Urol 1998, 33:28\u201331.","journal-title":"Eur Urol"},{"key":"21_CR56","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1464-410X.2001.02339.x","volume":"88","author":"C. Silva","year":"2001","unstructured":"Silva C, Avelino A, Souto-Moura C, Cruz F: A light and electron microscope histopathological study of the human bladder mucosa after intravesical resiniferatoxin application. BJU Int 2001, 88:355\u2013360.","journal-title":"BJU Int"}],"container-title":["Current Bladder Dysfunction Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11884-008-0021-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11884-008-0021-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11884-008-0021-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T19:26:56Z","timestamp":1738438016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11884-008-0021-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s11884-008-0021-8","relation":{},"ISSN":["1931-7212","1931-7220"],"issn-type":[{"type":"print","value":"1931-7212"},{"type":"electronic","value":"1931-7220"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}